| Literature DB >> 22542104 |
Jae Won Chang1, Micah J Niphakis, Kenneth M Lum, Armand B Cognetta, Chu Wang, Megan L Matthews, Sherry Niessen, Matthew W Buczynski, Loren H Parsons, Benjamin F Cravatt.
Abstract
The endocannabinoids 2-arachidonoyl glycerol (2-AG) and N-arachidonoyl ethanolamine (anandamide) are principally degraded by monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), respectively. The recent discovery of O-aryl carbamates such as JZL184 as selective MAGL inhibitors has enabled functional investigation of 2-AG signaling pathways in vivo. Nonetheless, JZL184 and other reported MAGL inhibitors still display low-level cross-reactivity with FAAH and peripheral carboxylesterases, which can complicate their use in certain biological studies. Here, we report a distinct class of O-hexafluoroisopropyl (HFIP) carbamates that inhibits MAGL in vitro and in vivo with excellent potency and greatly improved selectivity, including showing no detectable cross-reactivity with FAAH. These findings designate HFIP carbamates as a versatile chemotype for inhibiting MAGL and should encourage the pursuit of other serine hydrolase inhibitors that bear reactive groups resembling the structures of natural substrates.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22542104 PMCID: PMC3361572 DOI: 10.1016/j.chembiol.2012.03.009
Source DB: PubMed Journal: Chem Biol ISSN: 1074-5521